Vaccines & Immunization Pharmacology

A 12-month-old is due for MMR, but the parent says the child received a blood transfusion 3 weeks ago. Giving the vaccine now would be useless — do you know why?

Vaccines work by triggering active immunity — exposing the immune system to an antigen so it builds its own antibody memory. Live attenuated vaccines (MMR, varicella, rotavirus, intranasal influenza) contain weakened organisms that replicate briefly to provoke a robust immune response. They are contraindicated in immunocompromised clients and during pregnancy. Inactivated vaccines (DTaP, IPV, hepatitis B, pneumococcal) use killed organisms or subunits and cannot cause disease but often require multiple doses to build sufficient immunity. Passive antibodies from blood products or immunoglobulins neutralize live vaccine antigens before the child's immune system can respond, so live vaccines must be delayed (typically 3–11 months depending on the product). The CDC schedule is the testable standard: hepatitis B at birth, DTaP at 2-4-6-15–18 months, MMR and varicella at 12–15 months, with boosters at 4–6 years. Mild illness with low-grade fever is NOT a contraindication to vaccination. True contraindications include anaphylaxis to a prior dose or vaccine component and severe immunodeficiency for live vaccines.

Key Distinctions

Don't confuse live attenuated (MMR, varicella — contraindicated in immunosuppression and pregnancy) with inactivated vaccines (DTaP, IPV — safe in immunocompromised clients). Students often think a mild URI with low-grade fever is a reason to delay vaccines — it is not; only moderate-to-severe acute illness warrants deferral. Recent blood product administration delays live vaccines only, not inactivated ones.

Clinical Pearl

Live means alive — no pregnancy, no immunosuppression, no recent blood products. Think: 'If the patient can't fight, don't give anything that could fight back.'